REFERENCES
1. Kitano S, Inomata M, Mizusawa J, et al. Survival outcomes following laparoscopic versus open D3 dissection for stage II or III colon cancer (JCOG0404): a phase 3, randomised controlled trial. Lancet Gastroenterol Hepatol. 2017;2:261-8.
2. Lacy AM, García-Valdecasas JC, Delgado S, et al. Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet. 2002;359:2224-9.
3. Clinical Outcomes of Surgical Therapy Study Group; Nelson H, Sargent DJ, Wieand HS, et al. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med. 2004;350:2050-9.
4. Colon Cancer Laparoscopic or Open Resection Study Group; Buunen M, Veldkamp R, Hop WC, et al. Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Lancet Oncol. 2009;10:44-52.
5. Jayne DG, Guillou PJ, Thorpe H, et al; UK MRC CLASICC Trial Group. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol. 2007;25:3061-8.
6. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1:1479-82.
7. Gupta A, Dayal S, Moran BJ. Total mesorectal excision: embryology, anatomy, technique and outcomes. In: Kwaan M, Zbar A, editors. Comprehensive rectal cancer care. London: Springer Nature; 2019. pp. 125-46.
8. Ballantyne GH, Moll F. The da Vinci telerobotic surgical system: the virtual operative field and telepresence surgery. Surg Clin North Am. 2003;83:1293-304, vii.
9. Lee HJ, Choi GS, Park JS, et al. A novel robotic right colectomy for colon cancer via the suprapubic approach using the da Vinci Xi system: initial clinical experience. Ann Surg Treat Res. 2018;94:83-7.
10. Zihni AM, Ohu I, Cavallo JA, Cho S, Awad MM. Ergonomic analysis of robot-assisted and traditional laparoscopic procedures. Surg Endosc. 2014;28:3379-84.
11. Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.
12. Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008.
13. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
14. Jayne D, Pigazzi A, Marshall H, et al. Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer: the ROLARR randomized clinical trial. JAMA. 2017;318:1569-80.
15. Lanfranco AR, Castellanos AE, Desai JP, Meyers WC. Robotic surgery: a current perspective. Ann Surg. 2004;239:14-21.
16. Kwak JM, Kim SH. Robotic surgery for rectal cancer: an update in 2015. Cancer Res Treat. 2016;48:427-35.
17. Corrigan N, Marshall H, Croft J, Copeland J, Jayne D, Brown J. Exploring and adjusting for potential learning effects in ROLARR: a randomised controlled trial comparing robotic-assisted vs. standard laparoscopic surgery for rectal cancer resection. Trials. 2018;19:339.
18. Kim MJ, Park SC, Park JW, et al. Robot-assisted versus laparoscopic surgery for rectal cancer: a phase II open label prospective randomized controlled trial. Ann Surg. 2018;267:243-51.
19. Feng Q, Yuan W, Li T, et al; REAL Study Group. Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial. Lancet Gastroenterol Hepatol. 2022;7:991-1004.
20. Xu J, Yuan W, Li T, et al. Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): primary outcome of a multicenter randomized controlled trial. J Clin Oncol. 2024;42:3617.
21. Park JS, Lee SM, Choi GS, et al. Comparison of laparoscopic versus robot-assisted surgery for rectal cancers: the COLRAR randomized controlled trial. Ann Surg. 2023;278:31-8.
22. Giesen LJX, Dekker JWT, Verseveld M, et al. Implementation of robotic rectal cancer surgery: a cross-sectional nationwide study. Surg Endosc. 2023;37:912-20.
23. Park EJ, Kim CW, Cho MS, et al. Multidimensional analyses of the learning curve of robotic low anterior resection for rectal cancer: 3-phase learning process comparison. Surg Endosc. 2014;28:2821-31.
24. Ghadban T, Reeh M, Bockhorn M, et al. Minimally invasive surgery for colorectal cancer remains underutilized in Germany despite its nationwide application over the last decade. Sci Rep. 2018;8:15146.
25. Norwegian Institute of Public Health. Robotic surgery for rectal cancer: a health technology assessment. 2024. Available from: https://www.fhi.no/en/publ/2024/Robot-assisted-rectal-resection-for-rectal-cancer/. [Last accessed on 8 Jul 2025].
26. Duhoky R, Geitenbeek RTJ, Niccolò Piozzi G, et al. Ten years of robot-assisted versus laparoscopic total mesorectal excision for rectal cancer (short-term RESOLUTION). J Natl Cancer Inst. 2025:djaf084.
27. Hamabe A, Takemasa I, Kotake M, et al. Feasibility of robotic-assisted surgery in advanced rectal cancer: a multicentre prospective phase II study (VITRUVIANO trial). BJS Open. 2024;8:zrae048.
28. Thrikandiyur A, Kourounis G, Tingle S, Thambi P. Robotic versus laparoscopic surgery for colorectal disease: a systematic review, meta-analysis and meta-regression of randomised controlled trials. Ann R Coll Surg Engl. 2024;106:658-71.
29. Zhang C, Tan H, Xu H, Ding J. The role of robotic-assisted surgery in the management of rectal cancer: a systematic review and meta-analysis. Int J Surg. 2024;110:6282-96.
30. Matsuyama T, Endo H, Yamamoto H, et al. Outcomes of robot-assisted versus conventional laparoscopic low anterior resection in patients with rectal cancer: propensity-matched analysis of the National Clinical Database in Japan. BJS Open. 2021;5:zrab083.
31. Takemasa I, Hamabe A, Sakamoto Y, et al. Japanese multicenter prospective study investigating laparoscopic surgery for locally advanced rectal cancer with evaluation of CRM and TME quality (PRODUCT trial). Ann Gastroenterol Surg. 2022;6:767-77.
32. de’Angelis N, Schena CA, Azzolina D, et al; Association Française de Chirurgie (AFC). Histopathological outcomes of transanal, robotic, open, and laparoscopic surgery for rectal cancer resection. A Bayesian network meta-analysis of randomized controlled trials. Eur J Surg Oncol. 2025;51:109481.
33. Fleming CA, Cullinane C, Lynch N, Killeen S, Coffey JC, Peirce CB. Urogenital function following robotic and laparoscopic rectal cancer surgery: meta-analysis. Br J Surg. 2021;108:128-37.
34. Duhoky R, Rutgers MLW, Burghgraef TA, et al. Long-term outcomes of robotic versus laparoscopic total mesorectal excisions: a propensity-score matched cohort study of 5-year survival outcomes. Ann Surg Open. 2024;5:e404.
35. Sakai Y, Morishita T. The financial impact of robotic surgery on hospital gross profits in Japan compared to laparoscopic surgery. Asian J Endosc Surg. 2025;18:e13410.
36. Guerrero-Ortíz MA, Pellino G, Pascual Damieta M, et al; ROBOCOSTES Collaborative Group. Cost-effectiveness of robotic compared with laparoscopic rectal resection. Results from the Spanish prospective national trial ROBOCOSTES. Surgery. 2025;180:109134.
37. Matsuyama T, Kinugasa Y, Nakajima Y, Kojima K. Robotic-assisted surgery for rectal cancer: current state and future perspective. Ann Gastroenterol Surg. 2018;2:406-12.
38. Mathew J, Bansod YK, Yadav N, et al. Laparoscopic versus robotic lateral pelvic lymph node dissection in locally-advanced rectal cancer: a cohort study comparing perioperative morbidity and short-term oncological outcomes. Cancer Rep. 2025;8:e70174.
39. Zhu H, Zou J, Pan H, Huang Y, Chi P. Comparison of laparoscopic versus robot-assisted sugery for rectal cancer after neo-adjuvant therapy: a large volume single center experience. BMC Surg. 2025;25:98.
